Discontinuation report FRISIUM TABLET 10MG
| Report ID | 34601 |
| Drug Identification Number | 02221799 |
| Brand name | FRISIUM TABLET 10MG |
| Common or Proper name | clobazam |
| Company Name | LUNDBECK PHARMACEUTICALS LLC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLOBAZAM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 5 sheets of 6 foil blister cards in carton for a total of 30 tablets |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-08-31 |
| Actual discontinuation date | 2018-08-31 |
| Remaining supply date | 2018-08-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Product possible in distribution channel until depleted. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SIX PARKWAY NORTH, SUITE 400 DEERFIELD, ILLINOIS UNITED STATES 60015 |
| Company contact information | 1-866-880-4636 canadamedicalinformation@lundbeck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-09-18 | French | Compare |
| v3 | 2018-09-18 | English | Compare |
| v2 | 2018-01-02 | French | Compare |
| v1 | 2018-01-02 | English | Compare |
Showing 1 to 4 of 4